UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Drug Combination Studies of Isoquinolinone AM12 with Curcumin or Quercetin: A New Combination Strategy to Synergistically Inhibit 20S Proteasome

International journal of molecular sciences, 2024-10, Vol.25 (19), p.10708

2024

Volltextzugriff (PDF)

Rational design of NT-PSMA heterobivalent probes for prostate cancer theranostics

RSC medicinal chemistry, 2024-09

2024

Volltextzugriff (PDF)

Design, Synthesis, and In Vitro Characterization of Proteolytically-Stable Opioid-Neurotensin Hybrid Peptidomimetics

ACS pharmacology & translational science, 2024-09, Vol.7 (9), p.2784-2798

2024

Volltextzugriff (PDF)

SARS-CoV-2 molecular surveillance of migrant populations arriving to Italy via the Mediterranean Sea: lessons learnt

Epidemiologia e prevenzione, 2024-07, Vol.48 (4-5), p.69

2024

Volltextzugriff (PDF)

Identification of Dual Inhibitors Targeting Main Protease (Mpro) and Cathepsin L as Potential Anti-SARS-CoV‑2 Agents

ACS medicinal chemistry letters, 2024-05, Vol.15 (5), p.602-609

2024

Volltextzugriff (PDF)

The Inhibition of NS2B/NS3 Protease: A New Therapeutic Opportunity to Treat Dengue and Zika Virus Infection

International journal of molecular sciences, 2024-04, Vol.25 (8), p.4376

2024

Volltextzugriff (PDF)

Development of Novel Peptidyl Nitriles Targeting Rhodesain and Falcipain-2 for the Treatment of Sleeping Sickness and Malaria

International journal of molecular sciences, 2024-04, Vol.25 (8), p.4410

2024

Volltextzugriff (PDF)

Indole-Based Compounds as Potential Drug Candidates for SARS-CoV-2

Molecules (Basel, Switzerland), 2023-09, Vol.28 (18), p.6603

2023

Volltextzugriff (PDF)

Influence of amino acid size at the P3 position of N-Cbz-tripeptide Michael acceptors targeting falcipain-2 and rhodesain for the treatment of malaria and human african trypanosomiasis

Bioorganic chemistry, 2023-08, Vol.137, p.106587-106587, Article 106587

2023

Volltextzugriff (PDF)

Opening the amino acid toolbox for peptide‐based NTS2‐selective ligands as promising lead compounds for pain management

Journal of peptide science, 2023-06, Vol.29 (6), p.e3471-n/a

2023

Volltextzugriff (PDF)

Dipeptide Nitrile CD34 with Curcumin: A New Improved Combination Strategy to Synergistically Inhibit Rhodesain of Trypanosoma brucei rhodesiense

International journal of molecular sciences, 2023-05, Vol.24 (10), p.8477

2023

Volltextzugriff (PDF)

Dipeptide Nitrile CD34 with Curcumin: A New Improved Combination Strategy to Synergistically Inhibit Rhodesain of ITrypanosoma brucei rhodesiense/I

International journal of molecular sciences, 2023-05, Vol.24 (10)

2023

Volltextzugriff (PDF)

Design, Synthesis, and Biological Evaluation of the First Radio-Metalated Neurotensin Analogue Targeting Neurotensin Receptor 2

ACS omega, 2023-02, Vol.8 (7), p.6994-7004

2023

Volltextzugriff (PDF)

Structure-based lead optimization of peptide-based vinyl methyl ketones as SARS-CoV-2 main protease inhibitors

European journal of medicinal chemistry, 2023-02, Vol.247, p.115021, Article 115021

2023

Volltextzugriff (PDF)

Monoclonal Antibodies: The Greatest Resource to Treat Multiple Myeloma

International journal of molecular sciences, 2023-02, Vol.24 (4), p.3136

2023

Volltextzugriff (PDF)

Drug Combination Studies of the Dipeptide Nitrile CD24 with Curcumin: A New Strategy to Synergistically Inhibit Rhodesain of Trypanosoma brucei rhodesiense

International journal of molecular sciences, 2022-11, Vol.23 (22), p.14470

2022

Volltextzugriff (PDF)

Drug combination studies of PS-1 and quercetin against rhodesain of Trypanosoma brucei rhodesiense

Natural product research, 2022-08, Vol.36 (16), p.4282-4286

2022

Volltextzugriff (PDF)

Drug combination studies of PS-1 and quercetin against rhodesain of Trypanosoma brucei rhodesiense

Natural Product Research, 2022, Vol.36 (16), p.4282-4286

2022

Volltextzugriff (PDF)

Development of Urea-Bond-Containing Michael Acceptors as Antitrypanosomal Agents Targeting Rhodesain

ACS medicinal chemistry letters, 2022-07, Vol.13 (7), p.1083-1090

2022

Volltextzugriff (PDF)

Development of Reduced Peptide Bond Pseudopeptide Michael Acceptors for the Treatment of Human African Trypanosomiasis

Molecules (Basel, Switzerland), 2022-06, Vol.27 (12), p.3765

2022

Volltextzugriff (PDF)

Development of novel dipeptide nitriles as inhibitors of rhodesain of Trypanosoma brucei rhodesiense

European journal of medicinal chemistry, 2022-06, Vol.236, p.114328-114328, Article 114328

2022

Volltextzugriff (PDF)

Dual Inhibition of Parasitic Targets: A Valuable Strategy to Treat Malaria and Neglected Tropical Diseases

Current medicinal chemistry, 2022-01, Vol.29 (17), p.2952-2978

2022

Volltextzugriff (PDF)

Development of isoquinolinone derivatives as immunoproteasome inhibitors

Bioorganic & medicinal chemistry letters, 2022-01, Vol.55, p.128478-128478, Article 128478

2022

Volltextzugriff (PDF)

Metabolically stable neurotensin analogs exert potent and long-acting analgesia without hypothermia

Behavioural brain research, 2021-05, Vol.405, p.113189-113189, Article 113189

2021

Volltextzugriff (PDF)

Lead Discovery of SARS-CoV‑2 Main Protease Inhibitors through Covalent Docking-Based Virtual Screening

Journal of chemical information and modeling, 2021-04, Vol.61 (4), p.2062-2073

2021

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(45)
Berichte
(1)

Sprache

Englisch
(46)

Erscheinungsjahr

n.n

Thema

Science & Technology
(40)
Life Sciences & Biomedicine
(38)
Chemistry, Medicinal
(26)
Pharmacology & Pharmacy
(26)
Chemistry
(22)
Physical Sciences
(21)
Biochemistry & Molecular Biology
(17)
Humans
(15)
Chemistry, Multidisciplinary
(11)
Rhodesain
(11)
Structure-Activity Relationship
(8)
Animals
(7)
Chemistry, Organic
(7)
Cysteine Proteinase Inhibitors - Pharmacology
(7)
Life Sciences
(7)
Michael Acceptors
(7)
African Trypanosomiasis
(6)
Amino Acids
(6)
Curcumin
(6)
Cysteine Proteinase
(6)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

7 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Drug Combination Studies of Isoquinolinone AM12 with Curcumin or Quercetin: A New Combination Strategy to Synergistically Inhibit 20S Proteasome

Rational design of NT-PSMA heterobivalent probes for prostate cancer theranostics

Design, Synthesis, and In Vitro Characterization of Proteolytically-Stable Opioid-Neurotensin Hybrid Peptidomimetics

SARS-CoV-2 molecular surveillance of migrant populations arriving to Italy via the Mediterranean Sea: lessons learnt

Identification of Dual Inhibitors Targeting Main Protease (Mpro) and Cathepsin L as Potential Anti-SARS-CoV‑2 Agents

The Inhibition of NS2B/NS3 Protease: A New Therapeutic Opportunity to Treat Dengue and Zika Virus Infection

Development of Novel Peptidyl Nitriles Targeting Rhodesain and Falcipain-2 for the Treatment of Sleeping Sickness and Malaria

Indole-Based Compounds as Potential Drug Candidates for SARS-CoV-2

Influence of amino acid size at the P3 position of N-Cbz-tripeptide Michael acceptors targeting falcipain-2 and rhodesain for the treatment of malaria and human african trypanosomiasis

Opening the amino acid toolbox for peptide‐based NTS2‐selective ligands as promising lead compounds for pain management

Dipeptide Nitrile CD34 with Curcumin: A New Improved Combination Strategy to Synergistically Inhibit Rhodesain of Trypanosoma brucei rhodesiense

Dipeptide Nitrile CD34 with Curcumin: A New Improved Combination Strategy to Synergistically Inhibit Rhodesain of ITrypanosoma brucei rhodesiense/I

Design, Synthesis, and Biological Evaluation of the First Radio-Metalated Neurotensin Analogue Targeting Neurotensin Receptor 2

Structure-based lead optimization of peptide-based vinyl methyl ketones as SARS-CoV-2 main protease inhibitors

Monoclonal Antibodies: The Greatest Resource to Treat Multiple Myeloma

Drug Combination Studies of the Dipeptide Nitrile CD24 with Curcumin: A New Strategy to Synergistically Inhibit Rhodesain of Trypanosoma brucei rhodesiense

Drug combination studies of PS-1 and quercetin against rhodesain of Trypanosoma brucei rhodesiense

Drug combination studies of PS-1 and quercetin against rhodesain of Trypanosoma brucei rhodesiense

Development of Urea-Bond-Containing Michael Acceptors as Antitrypanosomal Agents Targeting Rhodesain

Development of Reduced Peptide Bond Pseudopeptide Michael Acceptors for the Treatment of Human African Trypanosomiasis

Development of novel dipeptide nitriles as inhibitors of rhodesain of Trypanosoma brucei rhodesiense

Dual Inhibition of Parasitic Targets: A Valuable Strategy to Treat Malaria and Neglected Tropical Diseases

Development of isoquinolinone derivatives as immunoproteasome inhibitors

Metabolically stable neurotensin analogs exert potent and long-acting analgesia without hypothermia

Lead Discovery of SARS-CoV‑2 Main Protease Inhibitors through Covalent Docking-Based Virtual Screening

Suchergebnisse filtern